Diseases produced by Clostridium perfringens type C

12
Diseases produced by Clostridium perfringens type C


Santiago S. Diab


Diseases of mammalian species


Introduction


Intestinal infection by C. perfringens type C causes necrotizing enteritis or enterocolitis in domestic animals and humans. The disease occurs mostly in neonatal individuals of several animal species. In lambs, type C infection is referred to as hemorrhagic enteritis, while in adult sheep, the term “struck” is used because of the very sudden nature of death. The term necrotic enteritis is used for type C disease in goats, cattle, pigs, and horses. In humans, type C disease is also known as enteritis necroticans, pigbel, or darmbrand. The disease has been reproduced experimentally in pigs, sheep, calves, and goats, while rabbits, mice, and guinea pigs have been used in experimental models to study diverse aspects of the pathogenesis of type C disease (Table 12.1).


Table 12.1 Most common spontaneous and experimental diseases associated with C. perfringens type C


Reprinted (slightly modified) with permission from Uzal et al. (2011) Vet. Microbiol., 153: 37–43.




































Spontaneous Sheep Hemorrhagic enteritis in lambs; “struck” in adult sheep
Pigs Necrotizing enteritis (mostly in piglets)
Cattle Necrotizing enteritis (mostly in calves)
Horses Necrotizing enteritis (mostly in foals)
Humans Enteritis necroticans (“pigbel,” “darmbrand”)
Experimental Rabbitsa Necrotizing enteritis (jejunum and ileum)
Miceb Depression, neurological disease, swollen abdomen, death. No significant damage to the intestine
Pigs Necrotizing enteritis (mainly jejunum and ileum; occasionally colon)
Guinea Pigs Necrotizing enteritis (mainly jejunum and ileum)
Necrotizing enteritis (mainly jejunum and ileum)
Necrotizing enteritis (mainly jejunum and ileum)
Sheep
Goats

aIntestinal loop model.


bIntragastric and intraduodenal model.


Etiology


C. perfringens type C has been associated with necrotizing enteritis in humans and domestic animals for many years. However, only in the last few years has the development of new research tools and the use of animal models (including pigs, guinea pigs, rabbits, mice, goats, and sheep) significantly expanded our understanding of the pathogenesis of type C infections. A detailed description of the toxins produced by C. perfringens is presented in Chapter 5. Briefly, all type C strains produce alpha (CPA) and beta (CPB) toxins. Additionally, certain strains of type C also produce other toxins, including, but not limited to, enterotoxin (CPE), beta2 toxin (CPB2), perfringolysin O (PFO), and the large clostridial toxin TpeL.


Molecular Koch’s postulates have been fulfilled for type C strains in several animal species, and it is now widely accepted that CPB plays a major role in the pathogenesis of C. perfringens type C disease and it is considered the most important virulence factor in type C infections. CPB is thermolabile and highly sensitive to proteases, including trypsin and pepsin, but it is resistant to low pH. It forms pores in the membranes of a variety of cultured cells, including endothelial cells of the intestinal mucosa of piglets and humans. These pores induce efflux of K+ and influx of Ca++, Na+ and Cl; resulting in cellular swelling and lysis. Recent research suggests that during infection by type C, CPB initially affects the host intestine indirectly by causing intestinal endothelial cell damage and subsequent thrombosis with ischemic necrosis of the intestinal mucosa. This, however, has not been definitively proved and others believe that initial damage by CPB occurs in intestinal epithelial cells. Whatever the mechanism, the extensive mucosal necrosis allows CPB, as well as other toxins and/or enteric bacteria, to reach the circulation and produce lethal systemic effects, including neurological effects in both natural and experimental disease. Experimentally, CPB is capable of inducing neurological alterations in mice when administered intragastrically, intraduodenally, or intravenously in the absence of significant intestinal damage. Neurological alterations can also occur in natural hosts of type C disease. The pathogenesis of the neurological alterations in CPB-intoxicated animals has not yet been established.


Epidemiology


The epidemiology of type C disease in different animal species is poorly understood. Limited available data indicate that the prevalence of the disease varies among animal species, but the case fatality rate is usually high for all of them. In non-vaccinated swine populations, the incidence may be nearly 100%, while case fatality rates vary from 50 to 100%. Litters from non-immune sows are particularly at risk. Adequate herd immunity may significantly decrease the incidence of the disease. “Struck” of adult sheep occurs primarily in pastured, non-vaccinated animals; its prevalence may range from 5 to 15%. The prevalence of infections in foals is low, but the case fatality rate ranges from 80 to 100%.


C. perfringens type C disease is typically a condition of young animals but occurs occasionally in adults, as in ovine “struck.” In swine, the disease can occur as early as 12 hours of age but is more commonly seen in 1- to 3-day-old piglets. Type C disease is rare in piglets older than 1 week. In foals, type C infection occurs most commonly during the first week of life. Lambs, goats, and calves may develop type C disease as early as the second day of life.


Pathogenesis


C. perfringens type C is found in soil and in feces and the intestinal tracts of humans and other animals, and spores survive in the environment for long periods of time. However, this microorganism is not typically considered an important commensal in the intestinal tract of most animal species. Its presence is rare in the intestines of healthy horses, but it is commonly found in the feces of pigs on farms where the disease is endemic. In vitro studies have shown that type C strains may transfer the plasmid carrying the CPB-encoding gene to type A strains and, although not yet proven, it has been suggested that this might also happen in vivo.


Environmental contamination with feces from infected animals is an important source of infection. For instance, small numbers of C. perfringens type C may be detected in the feces of sows, exposing piglets to the microorganism shortly after birth. Although the main source of infection for piglets is sow feces, piglets may also be a source of infection for other piglets. In vitro studies have shown that a pH between 6.5 and 7.5 leads to high production of CPA, CPB, CPB2, and CPE toxins by C. perfringens. Therefore, gastrointestinal factors that increase the luminal pH in the stomach may increase intestinal colonization, growth, and toxin production by C. perfringens.


Dietary changes are also considered important predisposing factors for the disease. A sudden change in the diet and other factors may cause an imbalance of the normal intestinal flora, which favours overgrowth of C. perfringens. As noted previously, CPB is protease-labile and disease only occurs in situations where protease activity is very low or absent. In neonates, this occurs due to early failure to produce protective quantities of proteases and also because of the protease-inhibitor effect of colostrum. Human enteritis necroticans has often been associated with routine consumption of a protein-poor diet with occasional consumption of high-protein food rich in trypsin inhibitors and contaminated with type C. A classic scenario has been documented in the Highlands of Papua New Guinea over the past 60 years, although it seems likely that these cases have occurred there over a much longer period. The primary diet consisted of sweet potato, which contains a protease inhibitor, but is also low in protein, leading to a protease deficiency in the small intestine. Consumption of undercooked meat from pigs slaughtered without careful attention to sanitation provided the source of infection with C. perfringens type C. Under these conditions, production of CPB in the intestine was followed by fulminant disease. In Papua New Guinea, there remains a significant incidence of this disease, where it is known in the native dialect as “pigbel” (pig belly). Vaccination with a beta toxoid was quite effective in children, but that vaccine is no longer in production and the incidence has risen as a result.


On occasion, even when adequate levels of trypsin are present in the intestinal lumen, high levels of CPB may overpower the neutralizing effects of trypsin and cause disease, possibly explaining cases of type C disease in adult animals. The presence of foods with high levels of trypsin inhibitors, such as sweet potato and soybeans, may predispose domestic animals to type C enteritis and enterotoxemia.


Concurrent infection with other pathogens can change the intestinal environment, creating circumstances that favor the proliferation of type C in the intestine. There is speculation that coinfection of pigs with transmissible gastroenteritis virus, porcine epidemic diarrhea virus, rotavirus, or coccidia may predispose to type C disease. In calves, concurrent infections with rotavirus, Cryptosporidium spp., and Salmonella spp. have been described, but whether these really predispose to type C infection is not known. In horses, both C. perfringens type C and C. difficile have been identified in foals with hemorrhagic enteritis or enterocolitis.


Clinical signs

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 28, 2017 | Posted by in GENERAL | Comments Off on Diseases produced by Clostridium perfringens type C

Full access? Get Clinical Tree

Get Clinical Tree app for offline access